Journal
ONCOGENE
Volume 22, Issue 26, Pages 4118-4127Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1206594
Keywords
senescence; immortalization; interferon gene silencing; LI-Fraumeni syndrome
Funding
- NCI NIH HHS [P30CA022453] Funding Source: Medline
Ask authors/readers for more resources
Abrogating cellular senescence is a necessary step in the formation of a cancer cell. Promoter hypermethylation is an epigenetic mechanism of gene regulation known to silence gene expression in carcinogenesis. Treatment of spontaneously immortal Li-Fraumeni fibroblasts with 5-aza-2'-deoxycytidine (5AZA-dC), an inhibitor of DNA methyltransferase (DNMT), induces a senescence-like state. We used microarrays containing 12 558 genes to determine the gene expression pro. le associated with cellular immortalization and also regulated by 5AZA-dC. Remarkably, among 85 genes with methylation-dependent downregulation (silencing) after immortalization, 39 (46%) are known to be regulated during interferon signaling, a known growth-suppressive pathway. This work indicates that gene silencing may be associated with an early event in carcinogenesis, cellular immortalization.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available